Cite
HARVARD Citation
Nagasawa, M. et al. (n.d.). 171 Preclinical studies support therapeutic application of the leukemic cell-based cancer relapse vaccine DCP-001 in ovarian cancer. Journal for immunotherapy of cancer. pp. A102-A103. [Online].